Navigation Links
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
Date:8/7/2009

to request that the Board fix a record date with respect to such stockholder action by written consent), the stockholder action by written consent executed and delivered by the Reporting Persons on August 5, 2009 is invalid and not effective.

However, the Company also notified the Reporting Persons that, in the event the Reporting Persons deliver to the Company a written notice, in compliance with Article II, Section 12 of the Company's By-Laws, requesting the Board to fix a record date for stockholder action by written consent, the Board intends to set a record date as provided in the Company's By-Laws.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx Corporation, the company's branded drug subsidiary.

For further information about KV Pharmaceutical Company, please visit the Company's corporate Web site at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

The information in this press release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning the operations, future results and prospects of the Company. Such statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "commit," "intend," "estimate," "will," "should," "could" and other expressions that indicate
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
2. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
3. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
4. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
5. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
7. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
8. ADVENTRX Pharmaceuticals Announces Financing
9. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
10. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... PARK, Calif. , May 26, 2015  Asterias ... on the emerging field of regenerative medicine, today announced ... in June 2014 were exercised prior to their expiry ... the Company of $11.7 million. "We thank ... Lichtinger , President and CEO of Asterias. "This exercise ...
(Date:5/26/2015)... San Bruno, CA (PRWEB) May 26, 2015 ... CRO, is officially joining the Alliance for Regenerative ... pioneering organizations, fostering research, development, investment, and commercialization ... , PRC Clinical, the California-based CRO ... strong expertise in stem cell and regenerative research ...
(Date:5/25/2015)... 2015 Phenome Networks, a software-as-a-service ... the availability, beginning May 31st, of its next-generation Phenome ... One solidifies Phenome Networks’ lead in the plant breeding ... and intuitive breeding workflow based on years of experience ... field design, and more. The new version of Phenome ...
(Date:5/22/2015)... , May 22, 2015 Baylor Research Institute ... Translational Genomics Research Institute (TGen) in ... focus on accelerating early detection and treatments for patients with ... both institutions will lead to new clinical trials and access ... bridging the gap from bench to bedside across Baylor ...
Breaking Biology Technology:Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 2Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 3PRC Clinical Joins 200+ Member Organizations in The Alliance for Regenerative Medicine (ARM) 2PRC Clinical Joins 200+ Member Organizations in The Alliance for Regenerative Medicine (ARM) 3Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4
... computing that you should improve processes before you automate them. ... could just get its act together and tell us clearly ... only objective is to automate what youre already doing, it ... of technology value on the table and presumes the luxury ...
... newsletter Source: Constant Contact MADISON For small businesses, ... concern and Business Filings Incorporated is working ... , ,Through a partnership with e-mail marketing company Constant ... 's Do-It-Yourself Email Marketing tools to new customers. Constant ...
... A fish tale that is about more than the one ... Clark illustrates how large the fish were MILWAUKEE The ... to commercialize the products of its research. It reached an ... new job as director of marketing and licensing for ...
Cached Biology Technology:Innovate, Automate, or Improve? You Don't Have to Choose. 2Innovate, Automate, or Improve? You Don't Have to Choose. 3Small businesses to benefit from Business Filings partnership 2Interview with Medical College of Wisconsin Research Foundation's new director of marketing and licensing 2Interview with Medical College of Wisconsin Research Foundation's new director of marketing and licensing 3
(Date:5/14/2015)... DUBLIN , May 14, 2015 Research and ... addition of the "Fingerprint Sensors Market in Smart ... This report believes that 2014 was a watershed ... to Apple,s introduction of ,Apple Pay,. Apple gave fingerprint ... its mobile payment service. Fingerprint sensors are a must-have ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/6/2015)... Israel , May 6, 2015 LifeBEAM, ... most established helmet producer, announced today that they will ... Helmet, the world,s first bio-sensing cycling helmet and the ... released in two new colors in order to give ... the product. In addition, LifeBEAM and Lazer announced their ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... by exposure to botulinum neurotoxins, which are among the ... Clostridium botulinum, a bacterium found in soil and food. ... neurons, interfering with nerve transmission and disrupting the communication ... Poisoning with botulinum toxins leads to an often-fatal paralysis, ...
... are now occurring more frequently than at any time in ... by Australian-based scientists. , Investigations by Associate Professor John Pandolfi, ... and The University of Queensland, of fossilized reefs in Papua ... disastrous events in past times. , "What we found ...
... and biological research are abuzz with the promises ... These Quantum Dots (QDs) have unique optical and electronic ... such as the detection and destruction of cancer ... is a comprehensive review of the latest literature ...
Cached Biology News:Coral stress 'like never in history' 2
... acrylic panels mounted on powder-coated ... a free-standing modular cleanroom that ... 3. Optional ceiling HEPA filter/fan ... configured to customer requirements. Negative-pressure ...
...
... fume hood ventilates and purifies ... release of exhaust. Bonded charcoal ... Configurations are available with vertical ... final HEPA filter, work bench ...
...
Biology Products: